U.S. Pharmaceutical Company Settles Lawsuit for $260 Million
An American pharmaceutical company agreed Monday to pay US$260 million to resolve allegations that it underpaid health care rebates and used a foundation as a conduit to pay illegal kickbacks in order to increase its drug prices.